An exercise intervention during chemotherapy for women with recurrent ovarian cancer: A feasibility study

International Journal of Gynecological Cancer

Volumn 25, Issue 6, 2015, Pages 985-992

  Mizrahi, David ^a,b   Broderick, Carolyn ^a   Friedlander, Michael ^a,c   Ryan, Mary ^c   Harrison, Michelle ^d   Pumpa, Kate ^e   Naumann, Fiona ^f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c ROYAL HOSPITAL FOR WOMEN   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF CANBERRA   (Australia)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Cancer; Chemotherapy; Exercise; Oncology; Physical activity; Quality of life

Indexed keywords

CARBOPLATIN; DOXORUBICIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; AEROBIC CAPACITY; AEROBIC EXERCISE; AGED; ARTICLE; BALANCE EXERCISE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CORE STABILITY EXERCISE; DEPRESSION; EXERCISE; FATIGUE; FEASIBILITY STUDY; FEMALE; HUMAN; MUSCLE STRENGTH; OVARY CANCER; PATIENT COMPLIANCE; PATIENT SAFETY; PHYSICAL ACTIVITY; PHYSICAL ACTIVITY, CAPACITY AND PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RESISTANCE TRAINING; SLEEP QUALITY; CANCER STAGING; EARLY CHILDHOOD INTERVENTION; FOLLOW UP; KINESIOTHERAPY; MIDDLE AGED; OVARIAN NEOPLASMS; PATHOLOGY; PROGNOSIS; TUMOR INVASION; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EARLY INTERVENTION (EDUCATION); EXERCISE THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; QUALITY OF LIFE;

EID: 84936942468     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000460     Document Type: Article

References (35)

1. Australian Institute of Health and Welfare & Australasian Association of Cancer Registries. Cancer in Australia: An Overview. Canberra: AIHW; 2012.
2. Feeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology. 2001; 38: 87-95.
3. Ushijima K. Treatment for recurrent ovarian cancerVat first relapse. J Oncol. 2010.
4. Olson SH, Mignone L, Nakraseive C, et al. Symptoms of ovarian cancer. Obstet Gynecol. 2001; 98: 212-217.
5. Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol. 2000; 78: 302-308.
6. Albrecht TA, Taylor AG. Physical activity in patients with advanced-stage cancer: a systematic review of the literature. Clin J Oncol Nurs. 2012; 16: 293-300.
7. Beaton R, Pagdin-Friesen W, Robertson C, et al. Effects of exercise intervention on persons with metastatic cancer: a systematic review. Physiother Can. 2009; 61: 141-153.
8. Donnelly CM, Blaney JM, Lowe-Strong A, et al. A randomised controlled trial testing the feasibility and efficacy of a physical activity behavioural change intervention in managing fatigue with gynaecological cancer survivors. Gynecol Oncol. 2011; 122: 618-624.
9. Moonsammy SH, Guglietti CL, Mina DS, et al. A pilot study of an exercise & cognitive behavioral therapy intervention for epithelial ovarian cancer patients. J Ovarian Res. 2013; 6: 21.
10. Newton MJ, Hayes SC, Janda M, et al. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study. BMC Cancer. 2011; 11: 389.
11. von Gruenigen VE, Frasure HE, Kavanagh MB, et al. Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy. Gynecol Oncol. 2011; 122: 328-333.
12. Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010; 42: 1409-1426.
13. Stevinson C, Capstick V, Schepansky A, et al. Physical activity preferences of ovarian cancer survivors. Psychooncology. 2009; 18: 422-428.
14. Stevinson H, Steed H, Faught W, et al. Physical activity in ovarian cancer survivors: associations with fatigue, sleep, and psychosocial functioning. Int J Gynecol Cancer. 2009; 19: 73-78.
15. Stevinson C, Faught W, Steed H, et al. Associations between physical activity and quality of life in ovarian cancer survivors. Gynecol Oncol. 2007; 106: 244-250.
16. Barnes EA, Bruera E. Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer. 2002; 12: 424-428.
17. Mock V, Pickett M, Ropka ME, et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract. 2001; 9: 119-127.
18. Levin L, Hryniuk WM. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol. 1987; 5: 756-767.
19. Johnson-Kozlow M, Sallis JF, Gilpin EA, et al. Comparative validation of the IPAQ and the 7-Day PAR among women diagnosed with breast cancer. Int J Behav Nutr Phys Act. 2006; 3: 7.
20. Beck SL, Schwartz AL, Towsley G, et al. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage. 2004; 27: 140-148.
21. McFarlane AC, McKenzie DP, Van Hooff M, et al. Somatic and psychological dimensions of screening for psychiatric morbidity: a community validation of the SPHERE Questionnaire. J Psychosom Res. 2008; 65: 337-345.
22. Stein KD, Jacobsen PB, Blanchard CM, et al. Further validation of the multidimensional fatigue symptom inventoryYshort form. J Pain Symptom Manage. 2004; 27: 14-23.
23. Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, et al. Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol. 2001; 19: 1809-1817.
24. Huang HQ, Brady MF, Cella D, et al. Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study. Int J Gynecol Cancer. 2007; 17: 387-393.
25. Golding L, Myers C, Sinning W. Y's Way to Physical Fitness, Champaign, IL: Human Kinetics Publishers, Inc, 1989.
26. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14: 377-381.
27. Howley ET. Type of activity: resistance, aerobic and leisure versus occupational physical activity. Med Sci Sports Exerc. 2001; 33: S364-369; discussion S419-320.
28. Speck RM, Courneya KS, Masse LC, et al. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2010; 4: 87-100.
29. Nishio K, Tanabe A, Maruoka R, et al. Bone mineral loss induced by anticancer treatment for gynecological malignancies in premenopausal women. Endocr Connect. 2013; 2: 11-17.
30. Quist M, Rorth M, Langer S, et al. Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study. Lung Cancer. 2012; 75: 203-208.
31. Rummans TA, Clark MM, Sloan JA, et al. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol. 2006; 24: 635-642.
32. Jones L, Haykowsky MJ, Swartz JJ, et al. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007; 50: 1435-1441.
33. Jones LW, Courneya KS, Mackey JR, et al. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol. 2012; 30: 2530-2537.
34. Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007; 25: 4396-4404.
35. Pinto BM, Frierson GM, Rabin C, et al. Home-based physical activity intervention for breast cancer patients. J Clin Oncol. 2005; 23: 3577-3587.